AKT1 and hepatocellular carcinoma: Many studies show PI3K/AKT pathway regulates chemotherapeutic drug resistance in HCC [24, 25]; our study also suggested STEAP4 inhibited HCC chemotherapy resistance through suppressing PI3K/AKT pathway.